Showing 1 - 11 results of 11 for search 'Fegan, C', query time: 0.06s
Refine Results
-
1
Increased frequency of CD4+PD‐1+HLA‐DR+ T cells is associated with disease progression in CLL by Elston, L, Fegan, C, Hills, R, Hashimdeen, SS, Walsby, E, Henley, P, Pepper, C, Man, S
Published 2019Journal article -
2
T-cell depletion with Campath-1H "in the bag" for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid... by Chakrabarti, S, MacDonald, D, Hale, G, Holder, K, Turner, V, Czarnecka, H, Thompson, J, Fegan, C, Waldmann, H, Milligan, D
Published 2003Journal article -
3
Telomere length is a critical determinant for survival in multiple myeloma by Hyatt, S, Jones, R, Heppel, N, Grimstead, J, Fegan, C, Jackson, G, Hills, R, Allan, J, Pratt, G, Pepper, C, Baird, D
Published 2017Journal article -
4
-
5
Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. by Chakrabarti, S, Milligan, D, Pillay, D, Mackinnon, S, Holder, K, Kaur, N, McDonald, D, Fegan, C, Waldmann, H, Hale, G, Rickinson, A, Steven, N
Published 2003Journal article -
6
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. by Chakrabarti, S, Avivi, I, Mackinnon, S, Ward, K, Kottaridis, P, Osman, H, Waldmann, H, Hale, G, Fegan, C, Yong, K, Goldstone, A, Linch, D, Milligan, D
Published 2002Journal article -
7
Telomere length is an independent prognostic marker in MDS but not in de novo AML by Williams, J, Heppel, N, Britt-Compton, B, Grimstead, J, Jones, R, Tauro, S, Bowen, D, Knapper, S, Groves, M, Hills, R, Pepper, C, Baird, D, Fegan, C
Published 2017Journal article -
8
Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. by Oscier, D, Dearden, C, Eren, E, Erem, E, Fegan, C, Follows, G, Hillmen, P, Illidge, T, Matutes, E, Milligan, D, Pettitt, A, Schuh, A, Wimperis, J
Published 2012Journal article -
9
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration. by Hale, G, Rebello, P, Brettman, L, Fegan, C, Kennedy, B, Kimby, E, Leach, M, Lundin, J, Mellstedt, H, Moreton, P, Rawstron, A, Waldmann, H, Osterborg, A, Hillmen, P
Published 2004Journal article -
10
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. by Chakrabarti, S, Mackinnon, S, Chopra, R, Kottaridis, P, Peggs, K, O'Gorman, P, Chakraverty, R, Marshall, T, Osman, H, Mahendra, P, Craddock, C, Waldmann, H, Hale, G, Fegan, C, Yong, K, Goldstone, A, Linch, D, Milligan, D
Published 2002Journal article -
11
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Soci... by Bird, J, Fuge, R, Sirohi, B, Apperley, J, Hunter, A, Snowden, J, Mahendra, P, Milligan, D, Byrne, J, Littlewood, T, Fegan, C, McQuaker, G, Pagliuca, A, Johnson, P, Rahemtulla, A, Morris, C, Marks, D
Published 2006Journal article